Treatment of periimplant diseases in humans. Treatment of periimplant mucositis

A randomised placebo controlled study to evaluate the effects of chlorhexidine in the treatment of periimplant mucositis assessing the outcome variables probing depth reduction and reduction in bleeding on probing.

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12606000089538

Enrollment

Registered

2006-03-02

Start date

2006-03-01

Completion date

2007-03-01

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of this study is to evaluate the treatment of periimplant infection (mucositis) with a follow up period of 3 months. Treatment will begin with professional mechanical cleaning around the implant in addition to home tooth-brushing twice daily for 4 weeks with antiseptic (chlorhexidine) gel or placebo gel. The placebo gel will be of the same appearance as the chlorhexidine gel. The gels will be in identical tubes with identical labelling except for individual subjects study numbers.

Interventions

Double blind, placebo controlled clinical trial for treatment of periimplant mucositis using mechanical plaque control in combination with Chlorhexidine gel. A pea-sized amount of Chlorhexidine gel (0.2% of 1mg) is applied with a soft toothbrush to the affected implant twice a day for 4 weeks. Reevaluation at 1 & 3 months

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

21 Years to No maximum

Healthy volunteers

Inclusion criteria

At least 1 dental implant with periimplant mucositis.

Exclusion criteria

Uncontrolled diabetes subjects requiring prophylactic antibiotics.

Outcome results